Xiaochao Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiaochao Huang has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Heng-Shan Wang
Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Guangxi Key Laboratory of Chemistry and Molecular Engineering of Medicinal Resources, University Engineering Research Center for Chemistry of Characteristic Medicinal Resources (Guangxi), Guangxi Normal University, 541004, China
11 shared publications Chunhao Yu
Huaiyin Inst Technol, Natl & Local Joint Engn Res Ctr Mineral Salt Deep, Green Chem & Proc Enhancement Technol, Huaian 223003, Peoples R China
7 shared publicationsMeng Wang
7 shared publicationsWeiwei Hu
Jiangsu Key Laboratory of Regional Specific Resource Pharmaceutical Transformation, Green Chemistry and Process Enhancement Technology, Huaiyin Institute of Technology, Huai'an 223003, China
6 shared publicationsYong Yang
Jiangsu Key Laboratory of Regional Specific Resource Pharmaceutical Transformation, Green Chemistry and Process Enhancement Technology Center, Huai'An University, Huai'an, 223003, China
6 shared publicationsZhikun Liu
Jiangsu Key Laboratory of Regional Specific Resource Pharmaceutical Transformation, Green Chemistry and Process Enhancement Technology Center, Huai'An University, Huai'an, 223003, China
5 shared publications
Latest Publications
- 14 October 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 321 (Pt 2) , 119428
Antitumor EF24 analogue-integrated platinum (IV) prodrugs induce autophagy-mediated immunogenic cell death and PD-L1 downregulation in colorectal cancer
- 14 October 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 321 (Pt 2) , 119428
Antitumor EF24 analogue-integrated platinum (IV) prodrugs induce autophagy-mediated immunogenic cell death and PD-L1 downregulation in colorectal cancer
- 8 March 2026
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 280, 113295
Multifunctional platinum(IV) complexes reverse cisplatin resistance in triple- negative breast cancer via ferroptosis and apoptosis
- 8 March 2026
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 280, 113295
Multifunctional platinum(IV) complexes reverse cisplatin resistance in triple- negative breast cancer via ferroptosis and apoptosis
- 17 February 2026
- Published by Elsevier in Bioorganic Chemistry
- Vol. 173, 109658
Novel platinum(IV) complexes trigger apoptosis and ferroptosis to conquer cisplatin resistance in triple-negative breast cancer
- 17 February 2026
- Published by Elsevier in Bioorganic Chemistry
- Vol. 173, 109658
Novel platinum(IV) complexes trigger apoptosis and ferroptosis to conquer cisplatin resistance in triple-negative breast cancer
- 9 January 2025
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 285, 117249
Discovery of novel dual tubulin and MMPs inhibitors for the treatment of lung cancer and overcoming drug resistance
- 9 January 2025
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 285, 117249
Discovery of novel dual tubulin and MMPs inhibitors for the treatment of lung cancer and overcoming drug resistance
- 5 October 2024
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 113, 117936
Discovery of dual-targeted molecules based on Olaparib and Rigosertib for triple-negative breast cancer with wild-type BRCA
- 5 October 2024
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 113, 117936
Discovery of dual-targeted molecules based on Olaparib and Rigosertib for triple-negative breast cancer with wild-type BRCA
- 19 November 2023
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 263, 115968
Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis
- 19 November 2023
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 263, 115968
Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis
- 2 April 2023
- Published by Elsevier in Bioorganic Chemistry
- Vol. 135, 106510
Antitumor activity and mechanisms of dual EGFR/DNA-targeting strategy for the treatment of lung cancer with EGFRL858R/T790M mutation
- 2 April 2023
- Published by Elsevier in Bioorganic Chemistry
- Vol. 135, 106510
Antitumor activity and mechanisms of dual EGFR/DNA-targeting strategy for the treatment of lung cancer with EGFRL858R/T790M mutation
- 1 May 2021
- Published by Elsevier in Bioorganic Chemistry
- Vol. 110, 104741
Dual-target platinum(IV) complexes exhibit antiproliferative activity through DNA damage and induce ER-stress-mediated apoptosis in A549 cells
- 1 May 2021
- Published by Elsevier in Bioorganic Chemistry
- Vol. 110, 104741
Dual-target platinum(IV) complexes exhibit antiproliferative activity through DNA damage and induce ER-stress-mediated apoptosis in A549 cells